Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Wntrix

PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of antibody drugs. The company develops medicines which combines capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 26 Glowing Star Place
  • The Woodlands, TX 77382
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Wntrix’s full profile, request a free trial.

Wntrix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Mar-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Wntrix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0

Wntrix Executive Team (1)

Name Title Board
Seat
Contact
Info
Qingyun Liu President & Director